跳至主要内容
临床试验/IRCT20190129042540N1
IRCT20190129042540N1已完成2 期

The effects of botulinum toxin type A injections on pain symptoms, quality of life and sleep quality of patients with diabetic neuropathy : A randomized double-blind clinical trial

Rafsanjan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 70 years(—)
性别
All

入选标准

  • Having type 2 diabetes for at least 3 years
  • 40-70 years old
  • providing a positive response to four or more questions in DN4 test
  • evidence of diabetic neuropathy in lower limb electrophysiological examination

排除标准

  • who were allergic to BTX-A
  • using other drugs to reduce neuropathic pain
  • a history of myasthenia gravis
  • subjects with distal muscle weakness
  • kidney dysfunction
  • history of alcohol use
  • post-operative patients
  • who initiated taking medication after the onset of the study
  • who used aminoglycosides
  • peripheral vascular obstructive disease

研究者

相似试验